UK prepares to announce prion-proof reprocessing
This article was originally published in Clinica
The UK government is preparing to announce measures aimed at eliminating the risk of surgical transmission of Creutzfeldt-Jakob disease (CJD) in reprocessed instruments, Nigel Tomlinson, chief scientific advisor to NHS Estates, has told Clinica. Within the next six months the government expects to issue advice on how to eliminate the infectivity of the prion protein associated with CJD by effectively making the molecule benign, he said.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.